Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs
Abstract Background Porcine pleuropneumonia, caused by Actinobacillus pleuropneumoniae, is a bacterial respiratory disease of swine. Acute outbreaks of the disease are often accompanied by high mortality and economic losses. As severe cases of the disease frequently require parenteral antibiotic tre...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Porcine Health Management |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40813-018-0089-2 |
_version_ | 1818241652704149504 |
---|---|
author | Doris Hoeltig Judith Rohde Birgit Brunner Klaus Hellmann Erik Grandemange Karl-Heinz Waldmann |
author_facet | Doris Hoeltig Judith Rohde Birgit Brunner Klaus Hellmann Erik Grandemange Karl-Heinz Waldmann |
author_sort | Doris Hoeltig |
collection | DOAJ |
description | Abstract Background Porcine pleuropneumonia, caused by Actinobacillus pleuropneumoniae, is a bacterial respiratory disease of swine. Acute outbreaks of the disease are often accompanied by high mortality and economic losses. As severe cases of the disease frequently require parenteral antibiotic treatment of the animals, the efficacy of a single, high dose of marbofloxacin was compared to a three-time application of a dose of enrofloxacin under experimental conditions. Methods A blinded, controlled, randomized and blocked dose confirmation study was conducted to test the efficacy and safety of a single dose of 8 mg/kg marbofloxacin (160 mg/ml, Forcyl® Swine, Vetoquinol SA, France) to treat acute porcine pleuropneumonia after experimental aerosol inoculation of pigs with A. pleuropneumoniae serotype 2. The results were compared to a three consecutive day treatment of 2.5 mg/kg enrofloxacin and a mock (saline) treatment. Criteria for the assessment of efficacy were severity of lung lesions, bacteriological cure and the course of clinical disease after treatment. Results: Thirty six nursery pigs were divided into three treatment groups: marbofloxacin (T1), enrofloxacin (T2) and mock (T3). Statistically significant superiority (p < 0.05) of marbofloxacin and enrofloxacin compared to the mock-treated group was demonstrated for all efficacy criteria. The need of rescue euthanasia due to severity of symptoms was significantly reduced in both treatment groups (T1: 1 pig; T2: 0 pigs; vs. T3: 8 pigs). On day 6 after treatment initiation, clinical cure was observed in 10 (T1), 10 (T2) but only 1 of the piglets in T3. Extent of lung lesions (mean of lung lesion score T1: 3.9, T2: 6.0, T3: 21.1) and bacteriological isolation from lung tissue (on day 6 after treatment initiation: T1 = 0 pigs; T2 = 1 pig; T3 = all pigs) were also significantly reduced within both treatment groups. There were no adverse events linked to the drug administration and no injection site reactions were observed. Conclusions Both applied antimicrobial treatments were proven safe and efficacious for the treatment of acute porcine pleuropneumonia. No statistically significant differences were detected between the antibiotic treatments. |
first_indexed | 2024-12-12T13:32:45Z |
format | Article |
id | doaj.art-059de94b36004a9bb806d155a99c3dd7 |
institution | Directory Open Access Journal |
issn | 2055-5660 |
language | English |
last_indexed | 2024-12-12T13:32:45Z |
publishDate | 2018-06-01 |
publisher | BMC |
record_format | Article |
series | Porcine Health Management |
spelling | doaj.art-059de94b36004a9bb806d155a99c3dd72022-12-22T00:23:01ZengBMCPorcine Health Management2055-56602018-06-014111010.1186/s40813-018-0089-2Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigsDoris Hoeltig0Judith Rohde1Birgit Brunner2Klaus Hellmann3Erik Grandemange4Karl-Heinz Waldmann5Clinic for Swine, Small Ruminants, forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, FoundationInstitute for Microbiology, University of Veterinary Medicine Hannover, FoundationKlifovet AGKlifovet AGVetoquinol SA, Research and Development CentreClinic for Swine, Small Ruminants, forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, FoundationAbstract Background Porcine pleuropneumonia, caused by Actinobacillus pleuropneumoniae, is a bacterial respiratory disease of swine. Acute outbreaks of the disease are often accompanied by high mortality and economic losses. As severe cases of the disease frequently require parenteral antibiotic treatment of the animals, the efficacy of a single, high dose of marbofloxacin was compared to a three-time application of a dose of enrofloxacin under experimental conditions. Methods A blinded, controlled, randomized and blocked dose confirmation study was conducted to test the efficacy and safety of a single dose of 8 mg/kg marbofloxacin (160 mg/ml, Forcyl® Swine, Vetoquinol SA, France) to treat acute porcine pleuropneumonia after experimental aerosol inoculation of pigs with A. pleuropneumoniae serotype 2. The results were compared to a three consecutive day treatment of 2.5 mg/kg enrofloxacin and a mock (saline) treatment. Criteria for the assessment of efficacy were severity of lung lesions, bacteriological cure and the course of clinical disease after treatment. Results: Thirty six nursery pigs were divided into three treatment groups: marbofloxacin (T1), enrofloxacin (T2) and mock (T3). Statistically significant superiority (p < 0.05) of marbofloxacin and enrofloxacin compared to the mock-treated group was demonstrated for all efficacy criteria. The need of rescue euthanasia due to severity of symptoms was significantly reduced in both treatment groups (T1: 1 pig; T2: 0 pigs; vs. T3: 8 pigs). On day 6 after treatment initiation, clinical cure was observed in 10 (T1), 10 (T2) but only 1 of the piglets in T3. Extent of lung lesions (mean of lung lesion score T1: 3.9, T2: 6.0, T3: 21.1) and bacteriological isolation from lung tissue (on day 6 after treatment initiation: T1 = 0 pigs; T2 = 1 pig; T3 = all pigs) were also significantly reduced within both treatment groups. There were no adverse events linked to the drug administration and no injection site reactions were observed. Conclusions Both applied antimicrobial treatments were proven safe and efficacious for the treatment of acute porcine pleuropneumonia. No statistically significant differences were detected between the antibiotic treatments.http://link.springer.com/article/10.1186/s40813-018-0089-2EnrofloxacinMarbofloxacinRespiratory diseaseSwineBacteriological cureFluoroquinolone |
spellingShingle | Doris Hoeltig Judith Rohde Birgit Brunner Klaus Hellmann Erik Grandemange Karl-Heinz Waldmann Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs Porcine Health Management Enrofloxacin Marbofloxacin Respiratory disease Swine Bacteriological cure Fluoroquinolone |
title | Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs |
title_full | Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs |
title_fullStr | Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs |
title_full_unstemmed | Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs |
title_short | Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs |
title_sort | efficacy of a one shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs |
topic | Enrofloxacin Marbofloxacin Respiratory disease Swine Bacteriological cure Fluoroquinolone |
url | http://link.springer.com/article/10.1186/s40813-018-0089-2 |
work_keys_str_mv | AT dorishoeltig efficacyofaoneshotmarbofloxacintreatmentonacutepleuropneumoniaafterexperimentalaerosolinoculationofnurserypigs AT judithrohde efficacyofaoneshotmarbofloxacintreatmentonacutepleuropneumoniaafterexperimentalaerosolinoculationofnurserypigs AT birgitbrunner efficacyofaoneshotmarbofloxacintreatmentonacutepleuropneumoniaafterexperimentalaerosolinoculationofnurserypigs AT klaushellmann efficacyofaoneshotmarbofloxacintreatmentonacutepleuropneumoniaafterexperimentalaerosolinoculationofnurserypigs AT erikgrandemange efficacyofaoneshotmarbofloxacintreatmentonacutepleuropneumoniaafterexperimentalaerosolinoculationofnurserypigs AT karlheinzwaldmann efficacyofaoneshotmarbofloxacintreatmentonacutepleuropneumoniaafterexperimentalaerosolinoculationofnurserypigs |